Company news

2024 02.29

Tigermed-Jyton Announces Acquisition of NAMSA China and Global Strategic Partnership with NAMSA

BEIJING, CHINA and TOLEDO, US –February 29, 2024—Tigermed-Jyton, a leading medical device CRO in China, and NAMSA, a global leader MedTech Contract Research Organization (CRO) offering global end-to-end development services, today announced Tigermed-Jyton’s acquisition of NAMSA China, as well as the exclusive China region partnership and global collaboration between Tigermed-Jyton and NAMSA.

2023 11.20

Exhibition Recap | Tigermed-Jyton at the MEDICA German Medical Exhibition 2023

The 55th MEDICA in Dusseldorf, Germany took place on November 13-16, 2023 at the Dusseldorf Exhibition Center.

2023 07.04

Powerful Association between Tigermed-Jyton and Shanghai SAPH Pharma-Tech | The Strategic Cooperation Signing Ceremony between Tigermed-Jyton and Shanghai SAPH Pharma-Tech is Successfully Completed

Powerful Association between Tigermed-Jyton and Shanghai SAPH Pharma-Tech | The ···

2023 06.02

Interpretation of Regulations | Hainan Boao Trial Pre-communication to Help Licensed Drugs and Medical Devices Carry out Real-world Study for Product Registration

On April 25, 2023,theCenter for Medical Device Evaluation, NMPA, Hainan Medical ···

2020 01.08

Tigermed-Jyton and Reunion Reached Strategic Cooperation to Jointly Promote R&D of High-Quality Medical Devices

The signing ceremony for strategic cooperation between Shanghai Reunion Biotechnology...

Home Prev 1 Next End

Advance Human Health through
Delivery Excellence

Subscribe to Receive Tigermed-Jyton's Regulatory Newsletter

Obtain the latest industry and regulatory updates on a monthly basis.

Tel：+86-400-0739-391

Email：consult@tigermedgrp.com

Add：Suite 808, Union Plaza, Chaowai Street, Chaoyang District, Beijing

China Postal Code：100020

About us

Service & Tech

News

Contact Us

京ICP备2021039767号

Cookies

TOP

Contacts